Revvity Inc (Revvity), formerly Perkinelmer Inc, offers products, services, and solutions for the diagnostics, life sciences, and applied markets. The company offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. Revvity also offers cord blood and tissue banking, laboratory and research services. Its products find application in atomic spectroscopy, cell imaging and analysis, chromatography, analysis and detection, DNA/RNA isolation, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia, Europe, and Americas. Revvity is headquartered in Waltham, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Revvity Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Revvity Inc Company Overview
- Revvity Inc Company Snapshot
- Revvity Inc Pipeline Products and Ongoing Clinical Trials Overview
- Revvity Inc - Pipeline Analysis Overview
- Business Description
- Revvity Inc - Key Facts
- Revvity Inc - Major Products and Services
- Revvity Inc Pipeline Products by Development Stage
- Revvity Inc Ongoing Clinical Trials by Trial Status
- Revvity Inc Pipeline Products Overview
- Accentis - Allergy
- Accentis - Allergy Product Overview
- Accentis - Autoimmune Disorders
- Accentis - Autoimmune Disorders Product Overview
- Accentis - Endocrine Disorders
- Accentis - Endocrine Disorders Product Overview
- Accentis - Infectious Diseases
- Accentis - Infectious Diseases Product Overview
- Anti-SARS-CoV-2 Elisa (IgA)
- Anti-SARS-CoV-2 Elisa (IgA) Product Overview
- Anti-SARS-CoV-2 Elisa (IgA) Clinical Trial
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay Product Overview
- Dexela Flat Panel X-ray Detector 2321
- Dexela Flat Panel X-ray Detector 2321 Product Overview
- Diagnostic Kit - Candida Krusei
- Diagnostic Kit - Candida Krusei Product Overview
- Diagnostic Kit - Candida Tropicalis
- Diagnostic Kit - Candida Tropicalis Product Overview
- Diagnostic Kit - Rubella Virus
- Diagnostic Kit - Rubella Virus Product Overview
- Diagnostic Kit - Yersinia Enterocolitica
- Diagnostic Kit - Yersinia Enterocolitica Product Overview
- Diagnostic Test - Chagas Disease
- Diagnostic Test - Chagas Disease Product Overview
- Diagnostic Test - HIV
- Diagnostic Test - HIV Product Overview
- Diagnostic Test - Preterm Birth
- Diagnostic Test - Preterm Birth Product Overview
- Dry Blood Spot Test - COVID-19
- Dry Blood Spot Test - COVID-19 Product Overview
- Evoya
- Evoya Product Overview
- GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA
- GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA Product Overview
- GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA
- GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA Product Overview
- GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA
- GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA Product Overview
- Human DcCoV Antigen ELISA
- Human DcCoV Antigen ELISA Product Overview
- Human HCoV-229E Antigen ELISA
- Human HCoV-229E Antigen ELISA Product Overview
- Human HCoV-HKU1 Antigen ELISA
- Human HCoV-HKU1 Antigen ELISA Product Overview
- Human HCoV-NL63 Antigen ELISA
- Human HCoV-NL63 Antigen ELISA Product Overview
- Human HCoV-OC43 Antigen ELISA
- Human HCoV-OC43 Antigen ELISA Product Overview
- Human MERS-CoV Antigen ELISA
- Human MERS-CoV Antigen ELISA Product Overview
- Human SARS-CoV Antigen ELISA
- Human SARS-CoV Antigen ELISA Product Overview
- IDS-i10 - Infectious Disease Assay
- IDS-i10 - Infectious Disease Assay Product Overview
- IDS-i10 - Allergy Assay
- IDS-i10 - Allergy Assay Product Overview
- IDS-iSYS - 17-beta Estradiol Assay
- IDS-iSYS - 17-beta Estradiol Assay Product Overview
- IDS-iSYS - Androstenedione Assay
- IDS-iSYS - Androstenedione Assay Product Overview
- IDS-iSYS - DHEA-S
- IDS-iSYS - DHEA-S Product Overview
- IDS-iSYS Bioactive PTH (1-84) Kit
- IDS-iSYS Bioactive PTH (1-84) Kit Product Overview
- IgE Allergy Test - DP 3134-1601-1 E
- IgE Allergy Test - DP 3134-1601-1 E Product Overview
- IgE Allergy Test - DP 3134-1601-2 E
- IgE Allergy Test - DP 3134-1601-2 E Product Overview
- Lyme C6/C10 Rapid Test
- Lyme C6/C10 Rapid Test Product Overview
- Optical Scatter Imaging System - Cancer
- Optical Scatter Imaging System - Cancer Product Overview
- PerkinElmer Five-Plex qPCR Assay
- PerkinElmer Five-Plex qPCR Assay Product Overview
- PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva
- PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva Product Overview
- RA Analyzer 10
- RA Analyzer 10 Product Overview
- Rapid Test - COVID-19
- Rapid Test - COVID-19 Product Overview
- Rapid Test Kit - MethylGlyoxal
- Rapid Test Kit - MethylGlyoxal Product Overview
- SARS Diagnostic Test
- SARS Diagnostic Test Product Overview
- SARS-CoV-2 Interferon-gamma Release Assay
- SARS-CoV-2 Interferon-gamma Release Assay Product Overview
- uChek Universal
- ViaCyte
- ViaCyte Product Overview
- Revvity Inc - Key Competitors
- Revvity Inc - Key Employees
- Revvity Inc - Key Employee Biographies
- Revvity Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Revvity Inc, Recent Developments
- Apr 29, 2024: Revvity Announces Financial Results for the First Quarter of 2024
- Apr 26, 2024: EUROIMMUN and ALPCO-GeneProof partner for CE-IVD assays
- Apr 25, 2024: Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing
- Apr 15, 2024: Revvity Signals Software’s New Synergy Solution Redefines Collaboration between Pharma and Contract Partners
- Apr 02, 2024: Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
- Mar 18, 2024: Celonic Launches the New GS-CHOVOLUTION System Based on Revvity’s CHOSOURCE Expression Platform
- Mar 18, 2024: Revvity launches newborn sequencing research workflow
- Mar 15, 2024: Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research
- Feb 12, 2024: Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
- Jan 25, 2024: Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Revvity Inc Pipeline Products and Ongoing Clinical Trials Overview
- Revvity Inc Pipeline Products by Equipment Type
- Revvity Inc Pipeline Products by Indication
- Revvity Inc Ongoing Clinical Trials by Trial Status
- Revvity Inc, Key Facts
- Revvity Inc, Major Products and Services
- Revvity Inc Number of Pipeline Products by Development Stage
- Revvity Inc Pipeline Products Summary by Development Stage
- Revvity Inc Ongoing Clinical Trials by Trial Status
- Revvity Inc Ongoing Clinical Trials Summary
- Accentis - Allergy - Product Status
- Accentis - Allergy - Product Description
- Accentis - Autoimmune Disorders - Product Status
- Accentis - Autoimmune Disorders - Product Description
- Accentis - Endocrine Disorders - Product Status
- Accentis - Endocrine Disorders - Product Description
- Accentis - Infectious Diseases - Product Status
- Accentis - Infectious Diseases - Product Description
- Anti-SARS-CoV-2 Elisa (IgA) - Product Status
- Anti-SARS-CoV-2 Elisa (IgA) - Product Description
- Anti-SARS-CoV-2 Elisa (IgA) - Protocol for the Collection of Clinical Samples for Evaluation and Implementation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay - Product Status
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay - Product Description
- Dexela Flat Panel X-ray Detector 2321 - Product Status
- Dexela Flat Panel X-ray Detector 2321 - Product Description
- Diagnostic Kit - Candida Krusei - Product Status
- Diagnostic Kit - Candida Krusei - Product Description
- Diagnostic Kit - Candida Tropicalis - Product Status
- Diagnostic Kit - Candida Tropicalis - Product Description
- Diagnostic Kit - Rubella Virus - Product Status
- Diagnostic Kit - Rubella Virus - Product Description
- Diagnostic Kit - Yersinia Enterocolitica - Product Status
- Diagnostic Kit - Yersinia Enterocolitica - Product Description
- Diagnostic Test - Chagas Disease - Product Status
- Diagnostic Test - Chagas Disease - Product Description
- Diagnostic Test - HIV - Product Status
- Diagnostic Test - HIV - Product Description
- Diagnostic Test - Preterm Birth - Product Status
- Diagnostic Test - Preterm Birth - Product Description
- Dry Blood Spot Test - COVID-19 - Product Status
- Dry Blood Spot Test - COVID-19 - Product Description
- Evoya - Product Status
- Evoya - Product Description
- GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA - Product Status
- GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA - Product Description
- GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA - Product Status
- GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA - Product Description
- GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA - Product Status
- GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA - Product Description
- Human DcCoV Antigen ELISA - Product Status
- Human DcCoV Antigen ELISA - Product Description
- Human HCoV-229E Antigen ELISA - Product Status
- Human HCoV-229E Antigen ELISA - Product Description
- Human HCoV-HKU1 Antigen ELISA - Product Status
- Human HCoV-HKU1 Antigen ELISA - Product Description
- Human HCoV-NL63 Antigen ELISA - Product Status
- Human HCoV-NL63 Antigen ELISA - Product Description
- Human HCoV-OC43 Antigen ELISA - Product Status
- Human HCoV-OC43 Antigen ELISA - Product Description
- Human MERS-CoV Antigen ELISA - Product Status
- Human MERS-CoV Antigen ELISA - Product Description
- Human SARS-CoV Antigen ELISA - Product Status
- Human SARS-CoV Antigen ELISA - Product Description
- IDS-i10 - Infectious Disease Assay - Product Status
- IDS-i10 - Infectious Disease Assay - Product Description
- IDS-i10 - Allergy Assay - Product Status
- IDS-i10 - Allergy Assay - Product Description
- IDS-iSYS - 17-beta Estradiol Assay - Product Status
- IDS-iSYS - 17-beta Estradiol Assay - Product Description
- IDS-iSYS - Androstenedione Assay - Product Status
- IDS-iSYS - Androstenedione Assay - Product Description
- IDS-iSYS - DHEA-S - Product Status
- IDS-iSYS - DHEA-S - Product Description
- IDS-iSYS Bioactive PTH (1-84) Kit - Product Status
- IDS-iSYS Bioactive PTH (1-84) Kit - Product Description
- IgE Allergy Test - DP 3134-1601-1 E - Product Status
- IgE Allergy Test - DP 3134-1601-1 E - Product Description
- IgE Allergy Test - DP 3134-1601-2 E - Product Status
- IgE Allergy Test - DP 3134-1601-2 E - Product Description
- Lyme C6/C10 Rapid Test - Product Status
- Lyme C6/C10 Rapid Test - Product Description
- Optical Scatter Imaging System - Cancer - Product Status
- Optical Scatter Imaging System - Cancer - Product Description
- PerkinElmer Five-Plex qPCR Assay - Product Status
- PerkinElmer Five-Plex qPCR Assay - Product Description
- PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva - Product Status
- PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva - Product Description
- RA Analyzer 10 - Product Status
- RA Analyzer 10 - Product Description
- Rapid Test - COVID-19 - Product Status
- Rapid Test - COVID-19 - Product Description
- Rapid Test Kit - MethylGlyoxal - Product Status
- Rapid Test Kit - MethylGlyoxal - Product Description
- SARS Diagnostic Test - Product Status
- SARS Diagnostic Test - Product Description
- SARS-CoV-2 Interferon-gamma Release Assay - Product Status
- SARS-CoV-2 Interferon-gamma Release Assay - Product Description
- uChek Universal - Product Description
- ViaCyte - Product Status
- ViaCyte - Product Description
- Revvity Inc, Key Employees
- Revvity Inc, Key Employee Biographies
- Revvity Inc, Other Locations
- Revvity Inc, Subsidiaries
- Revvity Inc, Joint Venture
- Glossary
- Revvity Inc Pipeline Products by Equipment Type
- Revvity Inc Pipeline Products by Development Stage
- Revvity Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Waters Corp
- Thermo Fisher Scientific Inc
- Shimadzu Corp
- Precipio Inc
- Harvard Bioscience Inc
- Bio-Rad Laboratories Inc
- Agilent Technologies Inc
